Sana Biotechnology, Inc.
SANA
$3.27
-$0.09-2.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -30.83% | -26.88% | -26.86% | -18.61% | -12.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.66% | -35.91% | -30.33% | -39.23% | -16.96% |
| Operating Income | 29.66% | 35.91% | 30.33% | 39.23% | 16.96% |
| Income Before Tax | 8.47% | 23.35% | -2.97% | 32.38% | 5.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.47% | 23.35% | -2.97% | 32.38% | 5.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.47% | 23.35% | -2.97% | 32.38% | 5.82% |
| EBIT | 29.66% | 35.91% | 30.33% | 39.23% | 16.96% |
| EBITDA | 30.38% | 37.08% | 31.38% | 40.75% | 17.26% |
| EPS Basic | 16.65% | 31.16% | 7.58% | 42.12% | 19.95% |
| Normalized Basic EPS | 36.86% | 44.23% | 39.67% | 48.57% | 29.88% |
| EPS Diluted | 16.65% | 31.16% | 7.59% | 42.12% | 19.95% |
| Normalized Diluted EPS | 36.86% | 44.23% | 39.45% | 48.42% | 29.67% |
| Average Basic Shares Outstanding | 9.63% | 9.99% | 12.02% | 17.36% | 18.68% |
| Average Diluted Shares Outstanding | 9.63% | 9.99% | 11.56% | 16.85% | 18.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |